But until we have that information, we shouldn't experiment with patients outside of a research setting." Next Steps and Useful Resources Want to discuss your weight loss options more
Sermorelin and Tesamorelin both act on the same GHRH receptor, but Tesamorelin is more clinically validated for the visceral-fat-reduction indication and produces more consistent reductions in deep abdominal fat in studies
Physicians and staff should understand hair-cycle biology, diffuse alopecia, trichoscopy, donor safety, nutritional contributors, medical therapy, shock loss, graft handling and expectation management
Overall, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, AE profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities such as frailty [6, 22, 24]